Keywords: Software Tools, Cancer
Motivation: Discrimination between true and false positive targets identified using PI-RADSv2 is needed to avoid unnecessary biopsies.
Goal(s): To investigate how quantitative analysis of prostate mpMRI through Habitat Risk Scoring (HRS) combined with PI-RADS can improve prostate lesion identification compared to using PI-RADS alone.
Approach: In prospective clinical trials lesions identified by PI-RADS and/or HRS were targeted through MRI/ultrasound fusion biopsies.
Results: Using HRS yields 100% NPV in the PI-RADS 3 cohort and increases PPV by 7.4% in the PI-RADS 4-5 cohort with respect to clinically significant cancer. Overall, the NPV and PPV increased by 21.4% and 13.2% respectively.
Impact: We present a quantitative imaging approach to complement the current standard for assessing prostate cancer risk in mpMRI data and demonstrate that the use of HRS strengthens fidelity in both positive and negative detections.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords